This report provides methodological information on how to obtain estimates of behavioral health outcomes for populations living on and off tribal lands and provides some initial estimates using NSDUH 2005 to 2014 data.
Search Results
This report uses the combined 2007 to 2012 National Surveys on Drug Use and Health (NSDUHs), the 2012 Treatment Episode Data Set (TEDS), and the 2012 National Survey of Substance Abuse Treatment Services (N-SSATS) to examine opioid use and treatment among women of childbearing age (aged 15 to 44).
This spotlight uses combined 2002 to 2012 National Survey on Drug Use and Health to examine marijuana and pain reliever use among veterans and non-veterans.
This CBHSQ short report uses data from the 2011 Treatment Episode Data Set – Discharges (TEDS-D) and the 2012 National Survey of Substance Abuse Treatment Services (N-SSATS) to provide a portrait of treatment discharges among those referred to treatment by the criminal justice system, hereafter referred to as criminal justice...
This report is the third (in a series of four) regarding the First Release Reports for the 2014 NSDUH. This report presents data from the 2002 through 2014 NSDUHs for substance use treatment and mental health service use among people aged 12 or older. Results are presented for adolescents aged...
This report describes changes in the 2014 and 2015 NSDUHs that were designed to increase the efficiency of data collection and processing and to improve the quality of the data collected. In 2014, changes were made in the sample sizes allocated to each state and to different age groups in...
These are behavioral health reports for each of the ten HHS regions of the United States. Each report utilizes data from the National Survey on Drug Use and Health (NSDUH), collected annually. The topics addressed in the reports include youth substance use, youth mental health and treatment, adult mental health...
This spotlight uses 2013 National Survey on Drug Use and Health to assess race/ethnic differences in the past year nonmedical use of prescription pain relievers among those aged 12 or older.
This report presents an evaluation of the coverage, overlap, biases, strengths, and weaknesses of three sources of data on the receipt of specialty substance use treatment: the National Survey on Drug Use and Health (NSDUH), the National Survey of Substance Abuse Treatment Services (N-SSATS), and the Treatment Episode Data Set...
This Drug Abuse Warning Network (DAWN) short report looks at the estimated number of emergency room visits for adverse reactions involving involving the prescription sleep qie zolpidem for 2005 through 2010. The report focuses on gender, age groups and other pharmaceuticals such as pain relievers, other anti-anxiety and insomnia medications...
This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency room visits involving attention deficit/hyperactivity disorder stimulant medications between 2005 and 2010. The report shows visits for nonmedical use, adverse reactions, visits involving other pharmaceuticals, illicit drugs or alcohol.
This National Survey on Drug Use and Health (NSDUH) short report shows inhalant use by adolescents 12 to 17 years old. It also looks at inhalant use by gender, race, region of the country, metro area, past year use and days used.
This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency department visits involving phencyclidine (PCP) between 2005 and 2011. The report specifically talks about age groups, gender and other drugs such as marijuana, cocaine, heroin and pharmaceuticals and trends over time.
This CBHSQ data review uses 2002 through 2011 National Survey on Drug Use and Health (NSDUH) data to examine recent trends in heroin initiation, including the role of nonmedical prescription pain reliever use in the heroin trend among persons aged 12 to 49. Data are presented for various age groups...
This report uses 2005 to 2011 National Survey on Drug Use and Health (NSDUH) to assess past year and past month nonmedical use of prescription-type drugs among persons aged 12 or older for rural non-metropolitan counties, urbanized non-metropolitan counties and metropolitan counties. Results are shown by age group, gender, and...